Currently predicting for Thu, 4 Jun 2026

LPCN Prediction Chart

LPCN Predictions History

Latest community submissions for LPCN.
Predictor Target Session Target Price Result Direction Accuracy Score
May 12, 2026 $2.23 -3.71% $2.33 X 95.87% 0
May 12, 2026 $2.43 +4.95% $2.33 V 95.50% 1
May 12, 2026 $2.39 +3.09% $2.33 V 97.35% 1
May 12, 2026 Bullish $2.33 X 1
Dec 29, 2025 $5.11 -2.29% $6.29 X 81.24% 0
Dec 29, 2025 $5.16 -1.43% $6.29 X 81.96% 0
Husmann Husmann @Husmann.22821
Dec 29, 2025 Bullish $6.29 V 1
May 27, 2025 $3.72 +3.83% $3.52 X 94.40% 0
May 27, 2025 $3.67 +2.39% $3.52 X 95.86% 0
Husmann Husmann @Husmann.22821
May 27, 2025 Bullish $3.52 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LPCN with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT LIPOCINE INC.
Lipocine
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone replacement therapy. The company's pipeline candidates also include LPCN 1144, an oral prodrug of bioident...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE